Coblation advantage Leverage ArthroCare's Coblation technology as a differentiator when proposing minimally invasive surgical solutions, highlighting precise tissue dissolution and reduced collateral damage to patients to appeal to surgeons and procurement teams seeking safer, faster recovery.

Core markets Target the two core product areas Sports Medicine and Ear, Nose, and Throat, while identifying adjacent opportunities in spine, wound care, urology, and gynecology to expand departmental procurement and cross-sell across specialties.

Patent risk Monitor ongoing patent litigation history and emphasize the strategic value of ArthroCare’s patented technologies in conversations with hospitals and distributors to address IP risk, licensing considerations, and long-term product roadmap confidence.

Growth potential Position ArthroCare as a growth play in a multi-billion dollar market by aligning sales pitches with high-value surgical centers and integrated supply chains that can benefit from a comprehensive device line and reusable instruments.

Tech stack Acknowledge current tech stack and digital maturity for potential partner integrations, such as integrating with consent management, cloud-based content, and secure hosting to streamline procurement portals, catalogs, and post-sale support.